Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cats twice as likely to survive snakebites than dogs
Cats in the study were twice as likely to survive being bitten by a snake than dogs.
Scientists investigate the reasons behind high survival rate.

Researchers at the University of Queensland have discovered that cats are twice as likely to survive a venomous snakebite than dogs.

In a study published in Comparative Biochemistry and Physiology, scientists compared the effects of different snake venoms on the blood clotting agents in cats and dogs.

They found that while only 32 per cent of dogs can survive being bitten by an eastern brown snake without antivenom, cats were twice as likely to survive at 66 per cent.

Even with antivenom treatment, cats have a significantly higher survival rate, but until now the reasons for this were unknown.

Using a coagulation analyser, researchers tested the effects of eastern brown snake venom, in addition to 10 additional venoms found around the world, on dog and cat plasma in the lab.

They found that all venoms acted faster on dog plasma than cat or human, suggesting that dogs would likely enter a state where blood clotting fails sooner, and are therefore more vulnerable to these snake venoms.

“The spontaneous clotting time of the blood – even without venom – was dramatically faster in dogs than in cats,” said lead author Professor Bryan Fry. “This suggests that the naturally faster clotting blood of dogs makes them more vulnerable to these types of snake venoms.”

Snakebite is a common occurrence for pet owners across the world and it can be fatal. This is in part due to a condition called ‘venom-induced consumptive coagulopathy', where an animal loses its ability to clot blood and sadly bleeds to death.

In Australia alone, the eastern brown snake alone is responsible for an estimated 76 per cent of reported domestic pet snakebites each year.

The researchers hope their insights can lead to a better awareness of the critically short time window to get treatment for dogs envenomed by snakes.

“As dog lovers ourselves, this study strikes close to home but it also has global implications,” said Dr Fry. “I’ve had two friends lose big dogs to snakebites, dying in less than ten minutes even though the eastern brown snakes responsible were not particularly large specimens.

“This underscores how devastatingly fast and fatal snake venom can be to dogs.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.